MedPath

hypertonic saline in bronchiolitis

Conditions
bronchiolitis
Registration Number
CTRI/2010/091/001227
Lead Sponsor
self
Brief Summary

this study is randomised, double blind, conrolled trial comparing hypertonic saline verses normal saline in treatment of bronchiolitis in moderately ill hospitalised children. primary outcome measured will be improvement in psi score and secondary outcome will be reduction in hospital stay.

Detailed Description

Not available

Recruitment & Eligibility

Sex
Not specified
Target Recruitment
250
Inclusion Criteria

Children with bronchiolitis (defined by prodrome of upper respiratory tract infection, including rhinorrhea, cough, and sometimes low-grade fever, which progresses to lower respiratory tract involvement, paroxysmal cough and dyspnoea), with pulmonary score index >0 and ≤ 6.

Exclusion Criteria

previous episode of wheezing; chronic cardiopulmonary disease; critical illness at presentation requiring admission to intensive care; or ventilatory support;the use of nebulised HS within the previous 12 hours;pulmonary score index > 6;.

Study & Design

Study Type
Not specified
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
imrovement in psi scorewhen psi score less than 3
Secondary Outcome Measures
NameTimeMethod
reduction in hospital staytime taken to achieve study end points

Trial Locations

Locations (1)

s ms hospital japur

🇮🇳

Jaipur, RAJASTHAN, India

s ms hospital japur
🇮🇳Jaipur, RAJASTHAN, India
dr B. S. Sharma
Principal investigator
drbssharma@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.